PT1467998E - Heterocompostos tetraciclicos como moduladores do receptor do estrogenio - Google Patents
Heterocompostos tetraciclicos como moduladores do receptor do estrogenioInfo
- Publication number
- PT1467998E PT1467998E PT02797167T PT02797167T PT1467998E PT 1467998 E PT1467998 E PT 1467998E PT 02797167 T PT02797167 T PT 02797167T PT 02797167 T PT02797167 T PT 02797167T PT 1467998 E PT1467998 E PT 1467998E
- Authority
- PT
- Portugal
- Prior art keywords
- heterocomposts
- tetracyclic
- estrogen receptor
- receptor modulators
- modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34195701P | 2001-12-19 | 2001-12-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1467998E true PT1467998E (pt) | 2006-08-31 |
Family
ID=23339719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT02797167T PT1467998E (pt) | 2001-12-19 | 2002-12-02 | Heterocompostos tetraciclicos como moduladores do receptor do estrogenio |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1467998B1 (pt) |
| JP (1) | JP2005513133A (pt) |
| CN (1) | CN1620457A (pt) |
| AR (1) | AR038661A1 (pt) |
| AT (1) | ATE321764T1 (pt) |
| AU (1) | AU2002362041A1 (pt) |
| BR (1) | BR0215152A (pt) |
| CA (1) | CA2471107A1 (pt) |
| CY (1) | CY1105361T1 (pt) |
| DE (1) | DE60210333T2 (pt) |
| DK (1) | DK1467998T3 (pt) |
| ES (1) | ES2264737T3 (pt) |
| HK (1) | HK1068875A1 (pt) |
| HU (1) | HUP0500103A3 (pt) |
| IL (1) | IL162295A0 (pt) |
| MX (1) | MXPA04006034A (pt) |
| NZ (1) | NZ533281A (pt) |
| PL (1) | PL371045A1 (pt) |
| PT (1) | PT1467998E (pt) |
| RU (1) | RU2305099C2 (pt) |
| WO (1) | WO2003053977A1 (pt) |
| ZA (1) | ZA200405653B (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7105679B2 (en) | 2001-12-19 | 2006-09-12 | Kanojia Ramesh M | Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
| US7329654B2 (en) * | 2001-12-19 | 2008-02-12 | Janssen Pharmaceutica N.V. | Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
| US8614204B2 (en) | 2003-06-06 | 2013-12-24 | Fibrogen, Inc. | Enhanced erythropoiesis and iron metabolism |
| EP1713820A1 (en) * | 2004-01-22 | 2006-10-25 | Eli Lilly And Company | Selective estrogen receptor modulators |
| US7759498B2 (en) | 2004-09-20 | 2010-07-20 | Janssen Pharmaceutica N.V | Tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| DE602006014843D1 (de) | 2005-06-15 | 2010-07-22 | Fibrogen Inc | Verwendung von hif 1alfa modulatoren zur behandlung von krebs |
| DE102006024032A1 (de) * | 2006-05-23 | 2007-11-29 | Voith Patent Gmbh | Anordnung zur Bandregelung |
| PH12012502419A1 (en) * | 2010-06-10 | 2022-03-21 | Seragon Pharmaceuticals Inc | Estrogen receptor modulators and uses thereof |
| JP2015500346A (ja) * | 2011-12-14 | 2015-01-05 | セラゴン ファーマシューティカルズ，インク． | エストロゲン受容体モジュレーターおよびその使用 |
| CN113135884B (zh) * | 2020-01-20 | 2023-03-10 | 西华大学 | 一种异色烯类化合物及其制备方法和用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL124481C (pt) * | 1964-11-04 | |||
| CA2214196A1 (en) * | 1996-09-26 | 1998-03-26 | Eli Lilly And Company | Benzo[b]indeno[2,1-d]thiophene compounds, intermediates, processes, compositions and methods |
| CA2275166C (en) * | 1996-12-13 | 2003-07-22 | Yoshitake Kanbe | Novel benzopyran derivatives |
-
2002
- 2002-12-02 PT PT02797167T patent/PT1467998E/pt unknown
- 2002-12-02 DK DK02797167T patent/DK1467998T3/da active
- 2002-12-02 CN CNA028281446A patent/CN1620457A/zh active Pending
- 2002-12-02 JP JP2003554693A patent/JP2005513133A/ja not_active Withdrawn
- 2002-12-02 HU HU0500103A patent/HUP0500103A3/hu unknown
- 2002-12-02 BR BR0215152-9A patent/BR0215152A/pt not_active IP Right Cessation
- 2002-12-02 PL PL02371045A patent/PL371045A1/xx not_active Application Discontinuation
- 2002-12-02 NZ NZ533281A patent/NZ533281A/en unknown
- 2002-12-02 MX MXPA04006034A patent/MXPA04006034A/es active IP Right Grant
- 2002-12-02 CA CA002471107A patent/CA2471107A1/en not_active Abandoned
- 2002-12-02 DE DE60210333T patent/DE60210333T2/de not_active Expired - Fee Related
- 2002-12-02 EP EP02797167A patent/EP1467998B1/en not_active Expired - Lifetime
- 2002-12-02 AT AT02797167T patent/ATE321764T1/de not_active IP Right Cessation
- 2002-12-02 WO PCT/US2002/038486 patent/WO2003053977A1/en active IP Right Grant
- 2002-12-02 AU AU2002362041A patent/AU2002362041A1/en not_active Abandoned
- 2002-12-02 ES ES02797167T patent/ES2264737T3/es not_active Expired - Lifetime
- 2002-12-02 RU RU2004118606/04A patent/RU2305099C2/ru not_active IP Right Cessation
- 2002-12-02 IL IL16229502A patent/IL162295A0/xx unknown
- 2002-12-18 AR ARP020104957A patent/AR038661A1/es unknown
-
2004
- 2004-07-15 ZA ZA200405653A patent/ZA200405653B/xx unknown
-
2005
- 2005-02-15 HK HK05101213A patent/HK1068875A1/xx not_active IP Right Cessation
-
2006
- 2006-06-08 CY CY20061100768T patent/CY1105361T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK1467998T3 (da) | 2006-07-31 |
| AU2002362041A1 (en) | 2003-07-09 |
| AR038661A1 (es) | 2005-01-26 |
| ZA200405653B (en) | 2006-06-28 |
| JP2005513133A (ja) | 2005-05-12 |
| WO2003053977A1 (en) | 2003-07-03 |
| ATE321764T1 (de) | 2006-04-15 |
| CN1620457A (zh) | 2005-05-25 |
| HK1068875A1 (en) | 2005-05-06 |
| CY1105361T1 (el) | 2010-03-03 |
| RU2004118606A (ru) | 2006-01-10 |
| EP1467998A1 (en) | 2004-10-20 |
| PL371045A1 (en) | 2005-06-13 |
| EP1467998B1 (en) | 2006-03-29 |
| MXPA04006034A (es) | 2005-03-31 |
| NZ533281A (en) | 2007-05-31 |
| HUP0500103A3 (en) | 2009-01-28 |
| ES2264737T3 (es) | 2007-01-16 |
| DE60210333T2 (de) | 2006-11-30 |
| DE60210333D1 (de) | 2006-05-18 |
| IL162295A0 (en) | 2005-11-20 |
| RU2305099C2 (ru) | 2007-08-27 |
| HUP0500103A2 (hu) | 2005-05-30 |
| BR0215152A (pt) | 2004-10-19 |
| CA2471107A1 (en) | 2003-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60327767D1 (de) | Tricyclische steroidhormonkernrezeptor-modulatoren | |
| PT1444215E (pt) | Derivados de 1,2,4-triadiazolio como moduladores do receptor de melanocortina | |
| IL183543A0 (en) | Estrogen receptor modulators | |
| IL182829A0 (en) | Estrogen receptor modulators | |
| PL374215A1 (en) | Selective estrogen receptor modulators | |
| NO20015272L (no) | Glukokortikoid reseptor modulatorer | |
| ATE268776T1 (de) | Benzodiazepinderivate als gaba-a- rezeptormodulatoren | |
| ATE293962T1 (de) | Adenosin-rezeptor modulatoren | |
| PT1404667E (pt) | Derivados de piperidina uteis como moduladores da actividade do receptor de quimiocina | |
| EP1699796A4 (en) | AZABICYCLIC HETEROCYCLES IN PLACE OF MODULATORS OF THE CANNABINOID RECEPTOR | |
| PT1492789E (pt) | Derivados de tropano como moduladores ccr5 | |
| HRP20130638T1 (en) | Cannabinoid receptor modulator | |
| CY1105361T1 (el) | Τετρακυκλικες ετepοενωσεις σαν ρυθμιστες υποδοχεα οιστρογονου | |
| EP1418900A4 (en) | SELECTIVE ESTROGEN RECEPTOR MODULATORS | |
| PL376803A1 (pl) | Nowe pochodne tetracykliczne zawierające heteroatomy, jako selektywne modulatory receptora estrogenowego | |
| DE602004014773D1 (de) | Pyrrol-2,5-dionderivate als modulatoren des liver-x-rezeptors | |
| EE200300346A (et) | Androgeensed 7-asendatud 11-halogeenosteroidid | |
| ATE404567T1 (de) | Nichtsteroidale progesteron rezeptor modulatoren | |
| IL172921A0 (en) | Cck-1 receptor modulators | |
| SI1467998T1 (sl) | Tetraciklicne heterospojine kot modulatorji estrogenskega receptorja | |
| DE60230808D1 (de) | Benzothiophene als adenosinrezeptormodulatoren | |
| ID30106A (id) | Pelarutan enzimatik modulator-modulator reseptor estrogen selektif | |
| HK1096405A1 (en) | Progesterone receptor modulators | |
| LT2000015A (lt) | Nesteroidiniai ligandai estrogeno receptoriui | |
| SI1697371T1 (sl) | Azabiciklični heterocikli kot modulatorji kanabinoidnega receptorja |